Emerging Infectious Disease ISSN: 1080-6059

Molecular Analysis of Plasmodium ovale Variants

Thin Thida Win*, Amadu Jalloh*, Indah Setyawati Tantular†, Takafumi Tsuboi‡, Marcelo Urbano Ferreira§, Masatsugu Kimura¶, and Fumihiko Kawamoto*

Author affiliations: *Nagoya University Graduate School of Medicine, Nagoya, Japan; †Airlangga University, Surabaya, Indonesia; ‡Ehime University, Matsuyama, Ehime, Japan; §University of São Paulo, São Paulo, Brazil; ¶Osaka City University Medical School, Osaka, Japan

Main Article

Figure 1

Different nucleotide sequences of the SSUrRNA genes among various Plasmodium ovale isolates. Numbers of nucleotides are based on the P. ovale clone 9 sequence. Boldface letters show different nucleotides in each isolate. Poc 1–2 and Pov 1–3 indicate two and three different sequences obtained from the classic and variant P. ovale isolates, respectively. Nigeria, Nigerian I/CDC strain; PNG, Papua New Guinean isolate; LS, a strain from the London School of Hygiene and Tropical Medicine. Please see

Figure 1. Different nucleotide sequences of the SSUrRNA genes among various Plasmodium ovale isolates. Numbers of nucleotides are based on the P. ovale clone 9 sequence. Boldface letters show different nucleotides in each isolate. Poc 1–2 and Pov 1–3 indicate two and three different sequences obtained from the classic and variant P. ovale isolates, respectively. Nigeria, Nigerian I/CDC strain; PNG, Papua New Guinean isolate; LS, a strain from the London School of Hygiene and Tropical Medicine. Please see www.cdc.gov/ncidod/eid/03-0411-G1.htm for a larger reproduction of this figure.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.